Pascal Hickey

436 total citations
15 papers, 300 citations indexed

About

Pascal Hickey is a scholar working on Immunology and Allergy, Physiology and Infectious Diseases. According to data from OpenAlex, Pascal Hickey has authored 15 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology and Allergy, 7 papers in Physiology and 2 papers in Infectious Diseases. Recurrent topics in Pascal Hickey's work include Allergic Rhinitis and Sensitization (11 papers), Food Allergy and Anaphylaxis Research (10 papers) and Asthma and respiratory diseases (7 papers). Pascal Hickey is often cited by papers focused on Allergic Rhinitis and Sensitization (11 papers), Food Allergy and Anaphylaxis Research (10 papers) and Asthma and respiratory diseases (7 papers). Pascal Hickey collaborates with scholars based in Canada, Australia and Austria. Pascal Hickey's co-authors include Mark Larché, Deepen Patel, Peter Couroux, Anne Marie Salapatek, Roderick P. Hafner, Paul Laidler, Allan J. McLean, Denis J. Morgan, Peter Angus and Jacques Hébert and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Pascal Hickey

15 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pascal Hickey Canada	8	240	185	67	26	25	15	300
José Carlos García-Robaina Spain	9	127 0.5×	84 0.5×	72 1.1×	16 0.6×	23 0.9×	14	238
David Romero‐Pérez Spain	8	110 0.5×	36 0.2×	180 2.7×	6 0.2×	23 0.9×	16	244
Tania Ramos Spain	6	207 0.9×	184 1.0×	107 1.6×	36 1.4×	43 1.7×	7	280
Yang Yie Sio Singapore	10	89 0.4×	125 0.7×	142 2.1×	28 1.1×	23 0.9×	27	281
E S Fedenko Russia	8	154 0.6×	69 0.4×	158 2.4×	21 0.8×	44 1.8×	48	240
Matthew Kwok United Kingdom	9	193 0.8×	71 0.4×	46 0.7×	12 0.5×	25 1.0×	14	218
Javier Marrugo Colombia	8	103 0.4×	50 0.3×	34 0.5×	19 0.7×	14 0.6×	27	189
I Diéguez Spain	9	267 1.1×	164 0.9×	103 1.5×	24 0.9×	74 3.0×	33	410
F.M. Garritsen Netherlands	10	192 0.8×	92 0.5×	274 4.1×	5 0.2×	61 2.4×	16	314
María José Ávila Spain	3	155 0.6×	44 0.2×	149 2.2×	12 0.5×	37 1.5×	5	353

Countries citing papers authored by Pascal Hickey

Since Specialization

Citations

This map shows the geographic impact of Pascal Hickey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Hickey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Hickey more than expected).

Fields of papers citing papers by Pascal Hickey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Hickey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Hickey. The network helps show where Pascal Hickey may publish in the future.

Co-authorship network of co-authors of Pascal Hickey

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Hickey. A scholar is included among the top collaborators of Pascal Hickey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Hickey. Pascal Hickey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Voskamp, Astrid, Hannah A. DeBerg, Mark Hew, et al.. (2023). Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy. 79(2). 485–498. 14 indexed citations

Valenta, Rudolf, Susanne Vrtala, Thomas Schlederer, et al.. (2021). Comparison of house dust mite sensitization profiles in allergic adults from Canada, Europe, South Africa and USA. Allergy. 76(7). 2177–2188. 34 indexed citations

Prickett, Sara R., et al.. (2019). Safety and Tolerability of a Novel Peptide-Based Immunotherapy for Peanut Allergy. Journal of Allergy and Clinical Immunology. 143(2). AB431–AB431. 10 indexed citations

Neighbour, Helen, Mena Soliman, Lisa M. Steacy, et al.. (2018). The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy. Clinical and Translational Allergy. 8(1). 15–15. 16 indexed citations

Singh, Amrit, Casey P. Shannon, Jenny Thiele, et al.. (2017). Investigating Immune Gene Signatures in Peripheral Blood from Subjects with Allergic Rhinitis Undergoing Nasal Allergen Challenge. The Journal of Immunology. 199(10). 3395–3405. 3 indexed citations

Patel, Deepen, et al.. (2015). Safety of House Dust Mite Synthetic Peptide Immuno-Regulatory Epitopes in Patients with House Dust Mite Allergy and Controlled Asthma. Journal of Allergy and Clinical Immunology. 135(2). AB142–AB142. 3 indexed citations

Neighbour, Helen, et al.. (2015). The Nasal Allergen Challenge Protocol of the Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): Validation in a Clinical Trial of Cat Synthetic Peptide Immunoregulatory Epitopes (Cat-SPIRE). Journal of Allergy and Clinical Immunology. 135(2). AB142–AB142. 2 indexed citations

Hafner, Roderick P., Mark Larché, Paul Laidler, Pascal Hickey, & Jacques Hébert. (2013). Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation. World Allergy Organization Journal. 6. P81–P81. 1 indexed citations

Larché, Mark, et al.. (2013). Safety and Tolerability of Escalating Doses of House Dust Mite- Peptide Antigen Desensitization (HDM-PAD). Journal of Allergy and Clinical Immunology. 131(2). AB37–AB37. 18 indexed citations

10.

Hafner, Roderick P., Peter Couroux, A. Salapatek, et al.. (2013). Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses. World Allergy Organization Journal. 6. P162–P162. 4 indexed citations

11.

Hickey, Pascal, et al.. (2013). Safety and Tolerability of Fel d 1-Derived Peptide Antigen Desensitization in Subjects with Controlled Asthma. Journal of Allergy and Clinical Immunology. 131(2). AB206–AB206. 1 indexed citations

12.

Patel, Deepen, Peter Couroux, Pascal Hickey, et al.. (2012). Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study. Journal of Allergy and Clinical Immunology. 131(1). 103–109.e7. 152 indexed citations

13.

White, Paul J., Pascal Hickey, Stephen J. Headey, et al.. (2012). Colloidal characteristics and formulation of pure protein particulate vaccines. Journal of Pharmacy and Pharmacology. 64(10). 1386–1393. 4 indexed citations

14.

White, Paul J., Jarrod E. Church, Chan‐Yen Kuo, et al.. (2008). Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants. Vaccine. 26(52). 6824–6831. 11 indexed citations

15.

Hickey, Pascal, Peter Angus, Allan J. McLean, & Denis J. Morgan. (1995). Oxygen supplementation restores theophylline clearance to normal in cirrhotic rats. Gastroenterology. 108(5). 1504–1509. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact